CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results
CRISPR Therapeutics Presents Positive Data on Allogeneic CRISPR-based CAR-T Cell Therapies at AACR 2018
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results
Horizon broadens industry-leading gene editing capabilities through extension of key CRISPR license and grant-funded research
Blackrock Announces Arrangements to Address Mailing of Meeting Materials Resulting from the Canada Post Strike
